Gestational diabetes affects approximately 10% of pregnant women in the United States, posing risks to both the mother and baby. While common, the incidence of this condition has been on the rise over the last two decades.
Early detection of gestational diabetes can lead to effective management and prevention of long-term health issues.
Some common symptoms of gestational diabetes include increased thirst, frequent urination, fatigue, and blurred vision. It is important for pregnant women to monitor their blood sugar levels regularly to detect any abnormalities.
The exact cause of gestational diabetes is not fully understood, but it is believed to be related to hormonal changes and insulin resistance during pregnancy. Women who are overweight, have a family history of diabetes, or are older than 25 are at a higher risk of developing gestational diabetes.
Treatment for gestational diabetes typically involves a combination of healthy eating, regular physical activity, and monitoring blood sugar levels. In some cases, insulin injections may be necessary to control blood sugar levels.
It is crucial for pregnant women with gestational diabetes to work closely with their healthcare provider to manage their condition and ensure the health of both themselves and their baby. By following a treatment plan and making necessary lifestyle changes, women with gestational diabetes can reduce the risk of complications during pregnancy and childbirth.
What is gestational diabetes?
During pregnancy, gestational diabetes arises from hormonal changes that restrict insulin usage by the mother, necessary for converting sugar into energy for cells.
As pregnancy progresses, the placenta produces more hormones, leading to an accumulation of glucose in the blood instead of being utilized by the cells.
Who is at risk for gestational diabetes?
Risk factors for gestational diabetes include a history of the condition, obesity, and a family history of diabetes or prediabetes.
Almost 90% of pregnant women have at least one risk factor for diabetes.
Who should be tested for gestational diabetes?
All pregnant women in the U.S. undergo screening for gestational diabetes between weeks 24 and 28 through a glucose tolerance test.
For those at high risk, testing should be conducted earlier in the pregnancy.
How is gestational diabetes treated?
The main goal of treatment is to prevent excessive fetal growth, which can be harmful to both the mother and the baby. Patients may need to adjust their diet, monitor their blood sugar levels, and, in some cases, use insulin or oral medication.
Dietary changes are often the most effective approach, and gestational diabetes typically resolves after delivery.
Other important aspects of treating gestational diabetes include regular physical activity, maintaining a healthy weight, and attending prenatal appointments to monitor the health of both the mother and the baby. It is also crucial for pregnant women with gestational diabetes to work closely with healthcare providers to ensure proper management of the condition and to prevent any complications.
What are the risks for mothers and babies?
Mothers with gestational diabetes have increased risks of hypertension, labor complications, and Cesarean delivery. Large babies can lead to delivery complications, and the child has a higher risk of diabetes and obesity, while the mother is at risk of developing type 2 diabetes later in life.
In addition to the mentioned risks, gestational diabetes can also increase the likelihood of pre-eclampsia, a serious condition characterized by high blood pressure and organ damage. Babies born to mothers with gestational diabetes are at a higher risk of being born prematurely or having breathing difficulties.
What are the risks for labor and delivery?
Maintaining stable blood sugar levels and ensuring no complications are present, delivery around 39-40 weeks is ideal to prevent issues like hypoglycemia in the newborn right after birth.
Vigilant monitoring of blood glucose during labor is essential for preventing complications for the baby.
In addition to monitoring blood sugar levels, it is important for women with diabetes to have a birth plan in place that includes the involvement of a multidisciplinary team, including an obstetrician, endocrinologist, and neonatologist. This team approach can help ensure the best possible outcome for both mother and baby.
What makes Yale Medicine’s approach to treating gestational diabetes stand out?
Researchers at Yale Medicine focus on studying the causes and treatments of diabetes, with a history of pioneering research on insulin pump technology and diabetes types.
Yale Medicine aims to provide the best treatment options to patients through cutting-edge research.
Maintaining a healthy pregnancy with diabetes involves following a nutritious eating plan, staying physically active, and effectively managing blood glucose levels.
Efficacious diabetes management before and during early pregnancy is crucial for ensuring the healthy development of major organs in the baby.
Before You Are Pregnant
Consulting healthcare providers before conception and during early pregnancy is vital for maintaining a healthy pregnancy with diabetes. Adjustments in diet, activity levels, and medications may be necessary.
Commencing prenatal vitamins with folic acid early can help reduce the risk of birth defects.
Establishing a proficient healthcare team specialized in managing diabetes and pregnancy is crucial.
It is important to regularly monitor blood sugar levels before and during pregnancy to ensure they are within a healthy range. Maintaining a balanced diet rich in fruits, vegetables, whole grains, and lean proteins can help manage blood sugar levels and support a healthy pregnancy.
In addition to regular exercise, taking prenatal yoga or attending prenatal fitness classes can help pregnant women with diabetes stay active and reduce stress levels.
Educating yourself about diabetes management during pregnancy and seeking support from healthcare providers, support groups, and online resources can help you navigate the challenges of pregnancy with diabetes.
What to Be Checked For
Diabetes (If You Don’t Already Have It)
Before pregnancy, it is essential to test for type 2 diabetes if at risk. Early detection and management are critical.
Your Weight
Discussing weight management with a healthcare provider is important to mitigate risks associated with obesity during pregnancy.
Thyroid Function
Thyroid function testing is crucial for women with diabetes due to its impact on fetal development.
Eye and Kidney Health
Eye exams and kidney screenings before pregnancy are vital, especially if retinopathy or nephropathy is present.
Checking Your Blood Glucose (Blood Sugar)
Blood glucose targets during pregnancy are lower to protect the baby. Close monitoring and adapting to changing needs are vital for the health of both mother and baby.
Managing diabetes during pregnancy requires additional effort due to bodily changes and altered symptoms.
Consult the healthcare team if struggling to stay within the target range or experiencing low blood glucose levels. Collaborate with the healthcare team to set and adjust goals before and during pregnancy.
Follow specific timings for checking blood glucose levels to stay within the target range. Consult with a doctor or diabetes educator to determine the best times based on your lifestyle.
Continuous glucose monitors (CGMs) can be utilized during pregnancy for constant monitoring, especially beneficial for type 1 diabetes.
Adjust the diet plan with guidance from a diabetes educator or dietitian. Overeating, especially in the first trimester, is unnecessary as no extra calories are required.
Focusing on preventing preeclampsia with daily baby aspirin after 12 weeks can reduce the risk, particularly for women with diabetes.
Open access peer-reviewed scientific and medical journals.
Open Access
Dove Medical Press is part of the OAI.
Reprints
Bulk reprints available for the pharmaceutical industry.
Favored Authors
Authors benefit from expedited paper processing.
Social Media
Study on early pregnancy glycemic levels and outcome.
Received: 16 April 2021
Accepted for publication: 8 July 2021
Published: 16 September 2021 Volume 2021:14 Pages 5703-5709
Checked for plagiarism: Yes
Peer reviewer comments: 3
Editor who approved publication: Dr. Scott Fraser
Naser Al-Husban, Diala Walid Abu-Hassan, Ayman Qatawneh, Zaid AlSunna, Yasmine Alkhatib, Seif Alnawaiseh, Moyasser Alkhatib, Maysa Yousef
Correspondence: Naser Al-Husban
Department of Obstetrics and Gynecology, School of Medicine, The University of Jordan, Amman, Jordan
Background: Variations in maternal fasting blood sugar (FBS) levels during early pregnancy may impact feto-maternal outcomes.
Objective: To evaluate the effects of maternal FBS levels above 80 but below 120 mg/dL compared to below 80 mg/dL.
Methods: Retrospective analysis of early pregnancy FBS and outcomes in two groups.
Results: Elevated FBS in early pregnancy correlated with a diagnosis of gestational diabetes and the need for intervention.
Conclusion: Heightened awareness of early pregnancy FBS levels can help reduce complications.
Keywords: fasting, fetomaternal, glycemic, outcome, pregnancy
Introduction
Maternal hyperglycemia below diabetes levels can impact feto-maternal outcomes, with studies showing associations with increased birth weight and complications due to maternal sugar levels.
In gestational diabetes, abnormal fetal growth may be observed early, but the influence of pre-diagnosis maternal glucose levels is uncertain.
The aim is to assess outcomes with maternal FBS levels ranging from 80 to 120 mg/dL compared to below 80 mg/dL.
Methods
Subject Selection and FBS Measurement
A retrospective study at Jordan University Hospital involving 218 first-time pregnant women with early pregnancy FBS. FBS levels were categorized as lower normal (
Gestational age was confirmed via early ultrasound before 16 weeks. FBS was measured using the GLUC3 cassette with a normal range of 70-110 mg/dL.
Data on age, BMI, FBS, pregnancy complications, and outcomes were collected. There was no significant difference in age or BMI between the groups. Group 2 exhibited a higher rate of GDM diagnosis and requirement for intervention compared to Group 1. There were no significant differences in outcomes like polyhydramnios between the groups.
Early monitoring of FBS levels during pregnancy can aid in mitigating future risks.
Patients with gestational diabetes mellitus (GDM) were identified based on their treatment (metformin or insulin) and dosage. GDM diagnosis was made using a standard 75 OGTT between 26-28 weeks of pregnancy. Normal blood glucose levels should be below 95 mg/dL while fasting, below 180 mg/dL after one hour, below 155 mg/dL after two hours, and below 140 mg/dL after three hours. Data on primary outcomes such as GDM and preterm birth were collected from patient records, antenatal appointments, and delivery records. Statistical analysis was done using SPSS version 16, presenting results as mean ± standard deviation for quantitative outcomes, and counts and percentages for qualitative outcomes. Associations were tested using ANOVA and χ2 test, with significance set at P < 0.05. The study was approved by the IRB and registered on clinicaltrials.gov, following the Helsinki declaration.
There were 130 women in group 1 and 88 in group 2, with no significant differences in maternal age or BMI. Group 2 had more cases of GDM, leading to the need for medication. Polyhydramnios was more common in group 2, but there were no other significant differences in outcomes. There was a notable link between FBS levels and the development of GDM, highlighting the importance of careful monitoring and early testing for pregnant women. Follow-up care for patients with hyperglycemia or GDM is crucial for better management and outcomes, with ongoing glucose screening recommended for GDM patients to prevent complications.
The study's strengths included a good sample size and consideration of various confounding factors like age, number of deliveries, and BMI. It aimed to investigate whether normal FBS levels in early pregnancy could signal potential risks and impacts on outcomes. While the sample size was adequate, conducting the study in different populations with a larger sample size could offer clearer insights. The retrospective nature of the study was a limitation, suggesting the need for a prospective study.
Approval for the study was granted by the institutional review board at Jordan University Hospital, with patient consent not required due to the retrospective nature of the research. Anonymity was maintained throughout data collection and manuscript preparation, following the Helsinki guidelines.